Treace Medical Concepts (TMCI) Operating Leases (2022 - 2026)

Treace Medical Concepts (TMCI) has 5 years of Operating Leases data on file, last reported at $13.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 2.57% year-over-year to $13.6 million; the trailing twelve-month figure through Mar 2026 stood at $13.6 million (down 2.57% YoY), and the FY2025 full-year result was $14.0 million, down 12.25% from the prior year.
• Operating Leases for Q1 2026 stood at $13.6 million, down from $14.0 million in the prior quarter.
• Across five years, Operating Leases topped out at $19.0 million in Q3 2022 and bottomed at $12.9 million in Q3 2025.
• The 5-year median for Operating Leases is $15.9 million (2023), against an average of $15.6 million.
• The widest annual swing landed in 2024, when Operating Leases advanced 4.65%; it then retreated 21.57% in 2025.
• A 5-year view of Operating Leases shows it stood at $15.5 million in 2022, then advanced by 2.27% to $15.9 million in 2023, then grew by 0.27% to $15.9 million in 2024, then declined by 12.25% to $14.0 million in 2025, then declined by 3.08% to $13.6 million in 2026.
• The last three Operating Leases figures came in at $13.6 million (Q1 2026), $14.0 million (Q4 2025), and $12.9 million (Q3 2025), per Business Quant data.

Peer Comparison